In turn, long-term outcomes, such as relapse-free survival and overall survival in PR3-ANCA-positive EGPA patients were similar to those in patients with GPA PR3-ANCA (186). The gene discussed is GYPA; the disease is eosinophilic granulomatosis with polyangiitis.